Trends in Endocrinology & Metabolism
ReviewFlavonoids in Bone Erosive Diseases: Perspectives in Osteoporosis Treatment
Section snippets
Flavonoids: Bone Homeostasis and Osteoporosis Treatment
Osteoporosis (OP) is a worldwide chronic progressive bone disease characterized by increased bone resorption leading to bone loss and reduced mineral content, which lead to increased risk of bone fractures (≥8.9 million fractures/year) [1]. OP is often associated with a reduced quality of life, due to disability, pain, and depression, often related to fractures (i.e., hip, vertebra, wrist). Primary OP occurs mainly with aging or during postmenopause, while secondary OP is related to various
Search Strategies and Results of Collected References
The following literature search was conducted in four different databases: MEDLINE, ScienceDirect, EMBASE, and Web of Science. The strings used in the bibliographic search were: (Osteoporosis AND Flavonoid). In the MEDLINE database (PubMed search engine) 377 articles were retrieved by considering publications written in English (AND "English" [language]) and published after 1 January 2015 (AND ("2015/01/01"[Date - Entrez]: "2020/04/30"[Date - Entrez])). Reviews (NOT Review [Publication Type])
Polyphenols: Flavonoid Classes in Bone Homeostasis
Polyphenols are secondary metabolites produced by plants as a defense against pathogens or UV radiation. Flavonoids are the most studied polyphenols for OP treatment, and numerous molecules have been isolated, identified, and characterized.
The term flavonoid is used to describe a broad collection of plant compounds characterized by a flavone ring that constitutes the backbone of the structure. They are ubiquitous molecules playing an integral role in the growth and development of plants. They
The Roles of Flavonoids in Bone Tissue Homeostasis
Numerous flavonoids regulate bone homeostasis by interacting with the different signal transduction pathways of bone tissue cells. Effects favoring osteoblastogenesis and an increase of OB activity with improved bone deposition are mainly exerted by flavonoids; some of these compounds also act by inhibiting osteoclastogenesis and OC activity.
During OB differentiation, some isoflavones, flavonols, and anthocyanins cause the upregulation of BMP-2 expression, some flavones, isoflavones, flavonols,
Perspectives on the Use of Flavonoids in OP
Flavonoids have beneficial and protective effects on pathological bone loss and OP development. Despite the continuing increase in knowledge on their mechanisms of action, mostly derived from in vitro and in vivo preclinical studies, to our knowledge there are still no purified phytochemical compounds marketed as supplements or drugs for OP treatment.
Among the possible treatment strategies with the use of purified compounds, it might be useful to administer compounds that simultaneously have an
Concluding Remarks
The flavonoids reported in this review have been shown to have predominantly protective actions aimed at hindering pathological bone loss, highlighting specific effects primarily on OBs, but also on OC differentiation and activity through the same interactors (Figure 3); however, few clinical trials have been conducted. Several preclinical studies have demonstrated the protective effects of flavonoids. Although the epigenetic roles of these compounds are certain [55], few studies have
Author Contributions
D.B. and E.D. conceived and designed the search strategy for articles, selected the bibliography, and wrote the manuscript. Vi.C., Va.C., A.D.L., and L.R. revised the section ‘Polyphenols: Flavonoid Classes in Bone Homeostasis’. C.G. provided pharmacological feedback. F.C. provided feedback in the epigenetics field. M.F. and G.G. provided critical feedback on the entire manuscript. D.B., E.D., Vi.C., A.D.L., Va.C., L.R., C.G., M.F., F.C., and G.G. approved the submitted version of the
References (57)
Deregulated miRNAs in bone health: epigenetic roles in osteoporosis
Bone
(2019)Characterization of two alternative interleukin (IL)-10 5′UTR mRNA sequences, induced by lipopolysaccharide (LPS) stimulation of peripheral blood mononuclear cells
Mol. Immunol.
(2009)- et al.
Toxicological and pharmacological concerns on oxidative stress and related diseases
Toxicol. Appl. Pharmacol.
(2013) Natural products for treatment of osteoporosis: the effects and mechanisms on promoting osteoblast-mediated bone formation
Life Sci.
(2016)Daidzein stimulates osteogenesis facilitating proliferation, differentiation, and antiapoptosis in human osteoblast-like MG-63 cells via estrogen receptor-dependent MEK/ERK and PI3K/Akt activation
Nutr. Res.
(2017)Differential effects of formononetin and cladrin on osteoblast function, peak bone mass achievement and bioavailability in rats
J. Nutr. Biochem.
(2011)Calycosin-7-O-β-D-glucopyranoside stimulates osteoblast differentiation through regulating the BMP/WNT signaling pathways
Acta Pharm. Sin. B
(2015)Comparative proteomic and metabolomic analysis reveal the antiosteoporotic molecular mechanism of icariin from Epimedium brevicornu Maxim
J. Ethnopharmacol.
(2016)Icariin inhibits RANKL-induced osteoclastogenesis via modulation of the NF-κB and MAPK signaling pathways
Biochem. Biophys. Res. Commun.
(2019)Icariin protects against glucocorticoid induced osteoporosis, increases the expression of the bone enhancer DEC1 and modulates the PI3K/Akt/GSK3β/β-catenin integrated signaling pathway
Biochem. Pharmacol.
(2017)
The ability of hesperidin compared to that of insulin for preventing osteoporosis induced by type I diabetes in young male albino rats: a histological and biochemical study
Exp. Toxicol. Pathol.
Effects of malvidin, cyanidin and delphinidin on human adipose mesenchymal stem cell differentiation into adipocytes, chondrocytes and osteocytes
Phytomedicine
Chemical partitioning and DNA fingerprinting of some pistachio (Pistacia vera L.) varieties of different geographical origin
Phytochemistry
Regulation of SIRT1 in cellular functions: role of polyphenols
Arch. Biochem. Biophys.
Combined bioavailable isoflavones and probiotics improve bone status and estrogen metabolism in postmenopausal osteopenic women: a randomized controlled trial
Am. J. Clin. Nutr.
Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial
Am. J. Clin. Nutr.
An estimate of the worldwide prevalence and disability associated with osteoporotic fractures
Osteoporos. Int.
Osteoporosis prevention, diagnosis, and therapy
JAMA
Guidelines for the management of osteoporosis and fragility fractures
Intern. Emerg. Med.
From estrogen-centric to aging and oxidative stress: a revised perspective of the pathogenesis of osteoporosis
Endocr. Rev.
Role of cytokines in postmenopausal bone loss
Curr. Osteoporos. Rep.
Association between postmenopausal osteoporosis and experimental periodontitis
Biomed. Res. Int.
Methylation of cytokines gene promoters in IL-1β-treated human intestinal epithelial cells
Inflamm. Res.
An overview and management of osteoporosis
Eur. J. Rheumatol.
Medical treatment for osteoporosis: from molecular to clinical opinions
Int. J. Mol. Sci.
Vitamin D level between calcium–phosphorus homeostasis and immune system: new perspective in osteoporosis
Curr. Osteoporos. Rep.
Potential antiosteoporotic agents from plants: a comprehensive review
Evid. Based Complement. Alternat. Med.
From inflammaging to healthy aging by dietary lifestyle choices: is epigenetics the key to personalized nutrition?
Clin. Epigenetics
Cited by (49)
Kaempferol attenuates wear particle-induced inflammatory osteolysis via JNK and p38-MAPK signaling pathways
2024, Journal of EthnopharmacologyA comprehensive review on environmental pollutants and osteoporosis: Insights into molecular pathways
2023, Environmental ResearchGraphene oxide decorated daidzein as an oral drug to ameliorate the oxidative stress and glucocorticoid-induced osteoporosis in vivo zebrafish model
2023, Journal of Drug Delivery Science and Technology
- 3
These authors contributed equally to this review